-
Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published.
-
-
Sasser H. Faltering promise: Vitamin E and heart disease. Altern Med Alert 2004;7(9):101-104.
-
A new portrait of CAM use in the United States. Altern Med Alert 2004;7(9):S1-S2.
-
-
Annual, or less frequent, surveillance intervals are effective for aneurysms < 45 mm in diameter.
-
The benefit of ICD therapy, compared to amiodarone therapy in patients with life-threatening arrhythmia, continues to increase over time, and long-term data support the use of an ICD as first line therapy for secondary prevention of sudden cardiac death.
-
The National Cholesterol Education Program (NCEP), a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.
-
-